Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-04-14 @ 7:32 PM
Study NCT ID:
NCT04803227
Status:
TERMINATED
Last Update Posted:
2022-01-04
First Post:
2021-02-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19
Sponsor:
Histogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-11
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-05-28
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-12
First Submit QC Date:
None
Study First Post Date:
2021-03-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-14
Last Update Post Date:
2022-01-04
Last Update Post Date Type:
ACTUAL